• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS CASHEL AAA BIFURCATE 34MM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS CASHEL AAA BIFURCATE 34MM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number AB3498CL
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Occlusion (1984); Stenosis (2263)
Event Date 01/01/1980
Event Type  Injury  
Manufacturer Narrative
The implant date is unknown.Additional information is pending and will be submitted within 30 days upon receipt.
 
Event Description
As reported, the 34mm aaa bifurcate main body iliac graft got severely occluded.Iliac needed to be reworked due to stenosis.The product is implanted so it is not possible to return it.
 
Manufacturer Narrative
Complaint conclusion: the 34mm aaa bifurcate main body iliac graft got severely occluded.Iliac needed to be reworked due to stenosis.The product was not returned for analysis.A product history record (phr) review of lot 17331114 revealed no anomalies or non-conformances during the manufacturing and inspection processes that can be associated with the reported event.The reported ¿in-stent peripheral artery restenosis¿ and ¿stent occlusion¿ could not be confirmed as the device was not returned for analysis.The exact cause could not be determined.Vessel characteristics or procedural factors may have contributed to the reported event but these remain unknown despite follow-ups.According to the safety information in the instructions for use ¿potential adverse events and potential device risks include, but are not limited to prosthesis occlusion/stenosis.Follow up procedure it is recommended that physicians conduct regular examinations and imaging for the patient¿s lifetime.Follow-up imaging should be decided based upon the physician¿s clinical assessment of the patient pre- and post-implantation of the stent graft.After endovascular graft placement, patients should be regularly monitored for perigraft flow, aneurysm growth or changes in the structure or position of the endovascular graft.Annual imaging is recommended, including abdominal radiographs to examine device integrity (stent fracture, separation between bifurcated device and proximal cuffs or limb extensions, if applicable); and contrast and non-contrast ct to examine aneurysm changes, perigraft flow, patency, tortuosity and progressive disease.If renal complications or other factors preclude the use of image contrast media, abdominal radiographs and duplex ultrasound may provide similar information.¿neither the phr nor the very limited information available suggests a design or manufacturing related cause for the reported event; therefore, no corrective/preventive action will be taken at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AAA BIFURCATE 34MM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
CORDIS CASHEL
cahir road
cashel, co. tipperary
EI 
MDR Report Key9531709
MDR Text Key175896033
Report Number9616099-2019-03439
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 01/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/13/2020
Device Model NumberAB3498CL
Device Catalogue NumberAB3498CL
Device Lot Number17331114
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 12/03/2019
Initial Date FDA Received12/30/2019
Supplement Dates Manufacturer Received01/31/2020
Supplement Dates FDA Received02/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-